Literature DB >> 27322851

Hematopoietic cell transplantation in MDS: undervalued and underutilized.

M R Grunwald1, B R Avalos1, E A Copelan1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27322851     DOI： 10.1038/bmt.2016.169

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  22 in total

1.  Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes.

Authors:  Gregory A Abel; Angel M Cronin; Oreofe O Odejide; Hajime Uno; Richard M Stone; David P Steensma
Journal:  Br J Haematol       Date:  2016-02-23       Impact factor: 6.998

2.  Now everyone has a donor for HSCT.

Authors:  Richard Champlin
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 3.  Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?

Authors:  Charlotte K Brierley; David P Steensma
Journal:  Curr Opin Hematol       Date:  2016-03       Impact factor: 3.284

4.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

5.  Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.

Authors:  Maria Teresa Voso; Susanna Fenu; Roberto Latagliata; Francesco Buccisano; Alfonso Piciocchi; Maria Antonietta Aloe-Spiriti; Massimo Breccia; Marianna Criscuolo; Alessandro Andriani; Stefano Mancini; Pasquale Niscola; Virginia Naso; Carolina Nobile; Anna Lina Piccioni; Mariella D'Andrea; Ada D'Addosio; Giuseppe Leone; Adriano Venditti
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

6.  Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.

Authors:  Thomas Prébet; Steven D Gore; Benjamin Esterni; Claude Gardin; Raphael Itzykson; Sylvain Thepot; François Dreyfus; Odile Beyne Rauzy; Christian Recher; Lionel Adès; Bruno Quesnel; C L Beach; Pierre Fenaux; Norbert Vey
Journal:  J Clin Oncol       Date:  2011-07-25       Impact factor: 44.544

7.  Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey.

Authors:  Mikkael A Sekeres; Jaroslaw P Maciejewski; Alan F List; David P Steensma; Andrew Artz; Arlene S Swern; Paul Scribner; John Huber; Richard Stone
Journal:  Oncologist       Date:  2011-04-08

8.  Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Authors:  Brian C Shaffer; Kwang Woo Ahn; Zhen-Huan Hu; Taiga Nishihori; Adriana K Malone; David Valcárcel; Michael R Grunwald; Ulrike Bacher; Betty Hamilton; Mohamed A Kharfan-Dabaja; Ayman Saad; Corey Cutler; Erica Warlick; Ran Reshef; Baldeep Mona Wirk; Mitchell Sabloff; Omotayo Fasan; Aaron Gerds; David Marks; Richard Olsson; William Allen Wood; Luciano J Costa; Alan M Miller; Jorge Cortes; Andrew Daly; Tamila L Kindwall-Keller; Rammurti Kamble; David A Rizzieri; Jean-Yves Cahn; Robert Peter Gale; Basem William; Mark Litzow; Peter H Wiernik; Jane Liesveld; Bipin N Savani; Ravi Vij; Celalettin Ustun; Edward Copelan; Uday Popat; Matt Kalaycio; Richard Maziarz; Edwin Alyea; Ron Sobecks; Steven Pavletic; Martin Tallman; Wael Saber
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

9.  A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Authors:  Corey S Cutler; Stephanie J Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

10.  Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.